tiprankstipranks
Trending News
More News >
Mesoblast Limited (AU:MSB)
ASX:MSB

Mesoblast Limited (MSB) Similar Shares

Compare
297 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Mesoblast Limited
AU$2.77
AU$3.55B
-21.21
51.37%
3 Buy
0 Hold
0 Sell
Strong Buy
Clinuvel Pharmaceuticals
AU$11.08
AU$616.97M
17.01
1.65%
2 Buy
0 Hold
0 Sell
Moderate Buy
Neuren Pharmaceuticals Limited
AU$19.01
$2.41B
16.28
42.93%
4 Buy
0 Hold
0 Sell
Strong Buy
Orthocell Ltd
AU$1.02
AU$276.51M
-28.41
-13.56%
0 Buy
0 Hold
0 Sell
Hold
Immutep Ltd
AU$0.26
AU$552.65M
-8.89
10.29%
2 Buy
0 Hold
0 Sell
Moderate Buy
Prescient Therapeutics Limited
AU$0.09
AU$93.58M
-9.78
122.50%

Performance Comparison

Ticker
Company Name
Price
Change
% Change
AU:MSB
Mesoblast Limited
2.77
0.94
51.37%
AU:CUV
Clinuvel Pharmaceuticals
12.29
0.20
1.65%
AU:NEU
Neuren Pharmaceuticals Limited
19.01
5.71
42.93%
AU:OCC
Orthocell Ltd
1.02
-0.16
-13.56%
AU:IMM
Immutep Ltd
0.38
0.03
10.29%
AU:PTX
Prescient Therapeutics Limited
0.09
0.05
125.00%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts